Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
Indian AI drug discovery firm gets $1M to focus on rare diseases
Peptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven drug discovery company said it will use its fresh funds to expand its research scope to cover rare diseases, adding to its existing work in cancer and inflammation.
Cipla raises...
A new audio recognition system in Japan that was initially developed for business record keeping is now assisting people with difficulty in hearing using generative AI.
Aisin Corporation, a manufacturer of automotive components under Toyota, developed the YYProbe mobile app during the pandemic as a speech-to-text tool for employees to keep business records.
When employees with hearing...
Jolly Good announces new palliative care VR training module
Jolly Good in the United States, in partnership with Harvard-affiliated Brigham and Women’s Hospital, has developed a new VR training module in palliative care communication.
They came up with the VR module to help medical professionals acquire the necessary communication skills to provide care to terminally ill patients and their...
Jolly Good developing CBT VR for Apple Vision Pro
Japanese medical VR provider Jolly Good has announced that it is developing a virtual reality-based cognitive behavioural therapy (CBT) programme for the spatial computer Apple Vision Pro.
The CBT VR on the Apple Vision Pro is intended to complement chronic pain treatment using opioids or serve as an alternative non-drug therapy. Similar VR-based...
A new generative AI tool has been made available to doctors in Japan that helps summarise long and detailed preliminary interviews of patients.
Japanese startup Ubie has recently launched a large-language model-based (LLM) feature on its AI-powered patient service platform.
HOW IT WORKS
The Medical Interview Summary Function is a new feature on the Ubie Medical Navi, a platform offering that...
FlexifyMe expanding beyond India with $1M seed funding
FlexifyMe, a health tech platform for chronic musculoskeletal pain management, has raised $1 million in a seed funding round led by Flipkart Ventures. This round also drew participation from GSF, iHub Anubhuti, Chandigarh Angels, Venture Catalyst, and OneCapital, among other investors.
Launched in 2021, the Indian startup combines traditional...
Coreline Soft debuts in KOSDAQ
Early this week, Coreline Soft made its debut on the Korea Exchange's secondary trading board KOSDAQ in South Korea.
Following this, the medical AI company said in a LinkedIn post that it will proceed in developing its product pipeline and expanding its solutions.
"In the rapidly evolving field of medical AI, we aim to solidify our leading position in the chest CT...
Japanese pharmaceutical company Eisai has established a new digital health business targeting dementia.
WHY IT MATTERS
Eisai's newly formed wholly-owned subsidiary, Theoria Technologies Co., seeks to "accelerate the development of a dementia ecosystem." This ecosystem, according to a press release, will empower people with dementia to "live their fullest lives."
Commencing business in April 2024...
Nesa obtains US FDA 510(k) for fibroid mapping tech
Indian femtech Nesa Medtech has received the United States Food and Drug Administration 510(k) clearance for its fibroid mapping tool.
Its Fibroid Mapping Reviewer Application assists in the diagnosis and planning of interventional procedures for patients with uterine fibroids. It generates a 3D model of the uterus from ultrasound images where...
def4.jpg "Person answering their front door and getting a delivery from another person")
